
July 14, 2022
Discovery of ligands for disrupting the SARS-CoV-2 interactome with human proteins using multipronged genetically encoded technologies
The proposed project will accelerate the drug development capabilities of 48Hour Discovery INC (48HD) to find high affinity drug candidates for treatment of COVID. The deliverable for this project will be high potential new drug candidates from 48HD’s drug discovery pipeline for COVID and other targets using unique molecular libraries of 48HD. The libraries are […]
Read More